Caliway Biopharmaceuticals
6919.TW
#3638
Rank
NZ$6.94 B
Marketcap
NZ$4.47
Share price
-2.42%
Change (1 day)
-59.45%
Change (1 year)

Financial Statements

Thumbnail Caliway Biopharmaceuticals Financial Statement 2025-h1

Financial Statement 2025-h1

Language: English

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2025-h1

Financial Statement 2025-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2025

Financial Statement 2025

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2024-h1

Financial Statement 2024-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2024

Financial Statement 2024

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2023-h1

Financial Statement 2023-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2023

Financial Statement 2023

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2022-h1

Financial Statement 2022-h1

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2022

Financial Statement 2022

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2021

Financial Statement 2021

Language: Chinese

View Financial Statement
Thumbnail Caliway Biopharmaceuticals Financial Statement 2020

Financial Statement 2020

Language: Chinese

View Financial Statement